Malin to raise €330m via IPO

Malin, the Irish-backed investment firm targeting privately-owned life-science companies, has surpassed its initial funding hopes, by raising up to €330m in what is being viewed as one of Europe’s largest ever IPOs for the life sciences market.

Malin to raise €330m via IPO

The newly-formed company, backed by former Elan executives, last month announced its intention to raise between €275m and €325m via an IPO. Yesterday, the company – which has been formed out of south Dublin-based firm Brandon Point Industries, which is run by former Elan executive John Given – announced that it has successfully raised up to €330m via committed gross proceeds of €302m and up to €28m of additional investment commitments.

The company, which intends to invest in lifescience firms who see trade sales or IPOs as premature moves, will have just over 30.2 million new ordinary shares, at a price of €10 per share admitted to the Irish Stock Exchange’s secondary market, the ESM, next Wednesday.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited